Literature DB >> 19725853

Are the extent, location, and score of segmental wall motion abnormalities related to cardiac resynchronization therapy response?

Xuedong Shen1, Wilbert S Aronow, Chandra K Nair, Mark J Holmberg, Tom Hee, Stephanie Maciejewski, Dennis J Esterbrooks.   

Abstract

BACKGROUND: We hypothesized that segmental wall motion abnormalities (WMAs) are related to cardiac resynchronization therapy (CRT) response.
METHODS: We studied 108 patients who received CRT, 69 with ischemic and 39 with nonischemic heart disease. A wall motion score index (WMSI) was analyzed using a 17-segment model and calculated by the total score/number of segments analyzed. A decrease of left ventricular end systolic volume > or =15% after CRT was defined as a positive response to CRT.
RESULTS: Of 108 patients, 1,054/1,836 segments (57%) had WMAs. The mean WMSI was 2.06 in patients with ischemic heart disease and 1.04 in patients with nonischemic heart disease (P < 0.0001). The area under the receiver operating characteristic curve for a WMSI predicting a positive response to CRT was 0.70 (P = 0.0001). The cutoff point was a WMSI < or =2 for prediction of a positive response to CRT. After adjustment for age, gender, and clinical features, the WMSI persistently related to CRT responders (P = 0.01). During 15-month follow-up, the percentage of CRT nonresponders in patients with a WMSI >2 was significantly higher (82%) compared to patients with a WMSI < or =2 (47%, P = 0.005) and nonischemic heart disease (36%, P < 0.001). In 59 patients with left ventricular mechanical dyssynchrony, the percentage of negative responders to CRT in patients with a WMSI >2, < or =2, and nonischemic heart disease were 53% (8 of 15), 16% (3 of 19) and 0% (0 of 25), respectively (P < 0.001).
CONCLUSIONS: A large extent of WMAs and a WMSI >2 predicted a poorer CRT response.

Entities:  

Mesh:

Year:  2009        PMID: 19725853     DOI: 10.1111/j.1540-8175.2009.00961.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  2 in total

Review 1.  Sex differences in device therapy for heart failure: utilization, outcomes, and adverse events.

Authors:  Naomi D Herz; Joseph Engeda; Robbert Zusterzeel; William E Sanders; Kathryn M O'Callaghan; David G Strauss; Samantha B Jacobs; Kimberly A Selzman; Ileana L Piña; Daniel A Caños
Journal:  J Womens Health (Larchmt)       Date:  2015-03-20       Impact factor: 2.681

2.  A new baseline scoring system may help to predict response to cardiac resynchronization therapy.

Authors:  Xuedong Shen; Chandra K Nair; Wilbert S Aronow; Mak J Holmberg; Madhu Reddy; Kishley Anand; Tom Hee; Aimin Chen; Xiang Fang; Stephanie Maciejewski; Dennis J Esterbrooks
Journal:  Arch Med Sci       Date:  2011-09-02       Impact factor: 3.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.